$2.76
Acasti Pharma is a biotechnology business based in the US. Acasti Pharma shares (ACST) are listed on the NASDAQ and all prices are listed in US Dollars.
Our top picks for where to buy Acasti Pharma stock
How to buy Acasti Pharma stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – ACST. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Acasti Pharma stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Acasti Pharma stock price (NASDAQ: ACST)
Use our graph to track the performance of ACST stocks over time.Acasti Pharma shares at a glance
Latest market close | $2.83 |
---|---|
52-week range | $1.72 - $3.59 |
50-day moving average | $2.95 |
200-day moving average | $2.80 |
Wall St. target price | $5.93 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-1.73 |
Is it a good time to buy Acasti Pharma stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Acasti Pharma price performance over time
Historical closes compared with the close of $2.83 from 2024-07-25
1 week (2024-07-19) | -0.35% |
---|---|
1 month (2024-06-27) | -4.71% |
3 months (2024-04-26) | -2.41% |
6 months (2024-01-26) | 10.98% |
1 year (2023-07-27) | 15.04% |
---|---|
2 years (2022-07-27) | 237.87% |
3 years (2021-07-27) | 515.22% |
5 years (2019-07-26) | 22.51% |
Acasti Pharma financials
Revenue TTM | $115,000 |
---|---|
Gross profit TTM | $120,000 |
Return on assets TTM | -9.25% |
Return on equity TTM | -19.82% |
Profit margin | 0% |
Book value | $6.57 |
Market Capitalization | $26.7 million |
TTM: trailing 12 months
Acasti Pharma share dividends
We're not expecting Acasti Pharma to pay a dividend over the next 12 months.
Have Acasti Pharma's shares ever split?
Acasti Pharma's shares were split on a 1:6 basis on 9 July 2023. So if you had owned 6 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Acasti Pharma shares – just the quantity. However, indirectly, the new 500% higher share price could have impacted the market appetite for Acasti Pharma shares which in turn could have impacted Acasti Pharma's share price.
Acasti Pharma share price volatility
Over the last 12 months, Acasti Pharma's shares have ranged in value from as little as $1.72 up to $3.59. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Acasti Pharma's is 1.548. This would suggest that Acasti Pharma's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Acasti Pharma overview
Acasti Pharma Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal betamethasone spray for the treatment of ataxia-telangiectasia; and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. The company was incorporated in 2002 and is headquartered in Princeton, New Jersey. .
Frequently asked questions
nullWhat percentage of Acasti Pharma is owned by insiders or institutions?
Currently 41.415% of Acasti Pharma shares are held by insiders and 21.362% by institutions. When does the fiscal year end for Acasti Pharma?
Acasti Pharma's fiscal year ends in March. Where is Acasti Pharma based?
Acasti Pharma's address is: 3009 boulevard de la Concorde East, Laval, QC, Canada, H7E 2B5 What is Acasti Pharma's ISIN number?
Acasti Pharma's international securities identification number is: CA00430K8730 What is Acasti Pharma's CUSIP number?
Acasti Pharma's Committee on Uniform Securities Identification Procedures number is: 00430K105
More guides on Finder
-
Opto review 2024: $0 commission, fractional theme investing
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
Put options explained
Learn the basics of put options: what they are, how they work and a few examples.
-
Best broker cash sweep rates for July 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 best day trading platforms of July 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
11 apps like Webull you need to consider
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
7 best ways to invest $10K
Check out our 7 ideas for how to invest $10K to maximize your money.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question